OTCMKTS:ECTE - Echo Therapeutics Stock Price, Price Target & More

$0.0071 0.00 (-5.33 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$0.0075
Today's Range$0.0071 - $0.0071
52-Week Range$0.0050 - $0.1050
Volume3,469 shs
Average Volume28,645 shs
Market Capitalization$90,000.00
P/E RatioN/A
Dividend YieldN/A
Beta1.57

About Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics logoEcho Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community. In addition, it has a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, use, market, import, and sell CGM to medical facilities and individual consumers in South Korea; and a license, development, and commercialization agreement with Medical Technologies Innovation Asia, Ltd to research, develop, manufacture, and use CGM in the People's Republic of China, Hong Kong, Macau, and Taiwan. The company was founded in 1989 and is headquartered in Iselin, New Jersey.

Receive ECTE News and Ratings via Email

Sign-up to receive the latest news and ratings for ECTE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ECTE
CUSIPN/A
Phone732-549-0128

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares12,000,000

How to Become a New Pot Stock Millionaire

Echo Therapeutics (OTCMKTS:ECTE) Frequently Asked Questions

What is Echo Therapeutics' stock symbol?

Echo Therapeutics trades on the OTCMKTS under the ticker symbol "ECTE."

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics Inc. (OTCMKTS:ECTE) released its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same quarter in the prior year, the business earned ($0.97) earnings per share. View Echo Therapeutics' Earnings History.

Who are some of Echo Therapeutics' key competitors?

Who are Echo Therapeutics' key executives?

Echo Therapeutics' management team includes the folowing people:
  • Mr. Alan W. Schoenbart CPA, Chief Exec. Officer, Chief Financial Officer and Director (Age 59)
  • Ms. Christine H. Olimpio, Director of Investor Relations & Corp. Communications

Has Echo Therapeutics been receiving favorable news coverage?

Media headlines about ECTE stock have been trending somewhat negative recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Echo Therapeutics earned a news impact score of -0.01 on Accern's scale. They also gave news coverage about the medical device company an impact score of 47.80 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Echo Therapeutics?

Shares of ECTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Echo Therapeutics' stock price today?

One share of ECTE stock can currently be purchased for approximately $0.0071.

How big of a company is Echo Therapeutics?

Echo Therapeutics has a market capitalization of $90,000.00.

How can I contact Echo Therapeutics?

Echo Therapeutics' mailing address is 99 WOOD AVENUE SOUTH SUITE 302, ISELIN NJ, 08830. The medical device company can be reached via phone at 732-549-0128 or via email at [email protected]


MarketBeat Community Rating for Echo Therapeutics (ECTE)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  139
MarketBeat's community ratings are surveys of what our community members think about Echo Therapeutics and other stocks. Vote "Outperform" if you believe ECTE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ECTE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Echo Therapeutics (OTCMKTS:ECTE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/20/2016 forward)

Earnings

Echo Therapeutics (OTCMKTS:ECTE) Earnings History and Estimates Chart

Earnings by Quarter for Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics (OTCMKTS ECTE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/16/2016Q3 2016($0.11)ViewN/AView Earnings Details
8/12/2016Q2($0.82)ViewN/AView Earnings Details
5/20/2016Q1($0.23)ViewN/AView Earnings Details
3/30/2016Q4 2015($0.12)ViewN/AView Earnings Details
11/16/2015Q3 15($0.16)ViewN/AView Earnings Details
8/14/2015Q215($0.97)ViewN/AView Earnings Details
5/15/2015Q1 15($0.72)ViewN/AView Earnings Details
4/15/2015Q4 2014($0.04)ViewN/AView Earnings Details
11/19/2014Q314($0.31)($0.43)$19.11 millionViewN/AView Earnings Details
8/14/2014Q214($0.23)($0.31)$22.56 million$19.10 millionViewN/AView Earnings Details
5/9/2014Q114($0.26)($0.23)$0.02 million$0.0191 millionViewN/AView Earnings Details
3/27/2014Q413($0.36)($0.35)$0.02 million($0.04) millionViewN/AView Earnings Details
11/7/2013($0.56)($0.48)$0.02 million$0.02 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.81)($0.51)$10.00 million$22.56 millionViewN/AView Earnings Details
5/10/2013Q1 2013($0.10)($0.13)$0.01 million$0.02 millionViewN/AView Earnings Details
3/18/2013Q4 2012($1.10)($1.10)ViewN/AView Earnings Details
11/8/2012Q312($0.09)($0.11)ViewN/AView Earnings Details
8/10/2012Q2 2012($0.70)($0.81)ViewN/AView Earnings Details
5/11/2012Q1 2012($0.70)($0.77)ViewN/AView Earnings Details
3/16/2012Q4 2011($0.60)($1.98)ViewN/AView Earnings Details
11/8/2011Q3 2011($0.60)($0.70)ViewN/AView Earnings Details
8/12/2011Q2 2011($0.60)($0.59)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.40)($1.10)ViewN/AView Earnings Details
3/21/2011Q4 2010($0.35)ViewN/AView Earnings Details
5/17/2010Q1 2010($0.88)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Echo Therapeutics (OTCMKTS:ECTE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Echo Therapeutics (OTCMKTS ECTE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.00%
Institutional Ownership Percentage: 0.03%
Insider Trading History for Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics (OTCMKTS ECTE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2015Alan Wayne SchoenbartCFOBuy2,500$1.44$3,600.00View SEC Filing  
5/20/2015Scott Wayne HollanderCEOBuy8,000$1.48$11,840.00View SEC Filing  
6/30/2014Mark NordlichtMajor ShareholderBuy65,739$2.20$144,625.80View SEC Filing  
6/26/2014Mark NordlichtMajor ShareholderBuy17,300$2.20$38,060.00View SEC Filing  
6/24/2014Mark NordlichtMajor ShareholderBuy16,961$2.20$37,314.20View SEC Filing  
12/10/2013Mark Nordlichtmajor shareholderBuy69,569$2.75$191,314.75View SEC Filing  
3/22/2013Robert F DomanDirectorBuy15,000$0.80$12,000.00View SEC Filing  
3/21/2013William GriecoDirectorBuy30,000$0.76$22,800.00View SEC Filing  
8/23/2012James Francis SmithDirectorBuy20,000$1.47$29,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Echo Therapeutics (OTCMKTS ECTE) News Headlines

Source:
DateHeadline
Natus Medical (BABY) versus Echo Therapeutics (ECTE) Head-To-Head ComparisonNatus Medical (BABY) versus Echo Therapeutics (ECTE) Head-To-Head Comparison
www.americanbankingnews.com - April 15 at 7:19 AM
Contrasting Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)Contrasting Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 13 at 9:18 PM
Head to Head Review: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)Head to Head Review: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 13 at 5:12 AM
Comparing Tonix Pharmaceuticals (TNXP) and Echo Therapeutics (ECTE)Comparing Tonix Pharmaceuticals (TNXP) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 9 at 1:18 PM
Financial Comparison: Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)Financial Comparison: Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 8 at 11:30 PM
Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE) Critical ReviewInnovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE) Critical Review
www.americanbankingnews.com - December 8 at 3:52 PM
Comparing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)Comparing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 8 at 8:40 AM
Comparing Echo Therapeutics (ECTE) and Tonix Pharmaceuticals (TNXP)Comparing Echo Therapeutics (ECTE) and Tonix Pharmaceuticals (TNXP)
www.americanbankingnews.com - December 7 at 5:30 AM
Comparing Echo Therapeutics (ECTE) & Innovus Pharmaceuticals (INNV)Comparing Echo Therapeutics (ECTE) & Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - December 3 at 4:38 PM
Reviewing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)Reviewing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 2 at 1:06 PM
Analyzing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)Analyzing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 2 at 5:36 AM
Head to Head Contrast: Echo Therapeutics (ECTE) versus Innovus Pharmaceuticals (INNV)Head to Head Contrast: Echo Therapeutics (ECTE) versus Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - December 1 at 11:38 AM
Critical Analysis: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)Critical Analysis: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 30 at 5:28 PM
Head-To-Head Comparison: Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)Head-To-Head Comparison: Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - November 29 at 7:56 PM
Echo Therapeutics (ECTE) & Tonix Pharmaceuticals (TNXP) Head-To-Head AnalysisEcho Therapeutics (ECTE) & Tonix Pharmaceuticals (TNXP) Head-To-Head Analysis
www.americanbankingnews.com - November 27 at 5:28 AM
Comparing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)Comparing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 24 at 11:16 PM
Comparing Tonix Pharmaceuticals Holding Corp. (TNXP) and Echo Therapeutics (ECTE)Comparing Tonix Pharmaceuticals Holding Corp. (TNXP) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 23 at 5:24 AM
Reviewing Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)Reviewing Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - November 21 at 9:55 AM
Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) vs. Echo Therapeutics (ECTE)Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) vs. Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 20 at 7:52 PM
Echo Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head ContrastEcho Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head Contrast
www.americanbankingnews.com - November 20 at 11:50 AM
Contrasting Echo Therapeutics (ECTE) & Tonix Pharmaceuticals Holding Corp. (TNXP)Contrasting Echo Therapeutics (ECTE) & Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - November 20 at 7:54 AM
Financial Contrast: Echo Therapeutics (ECTE) vs. Tonix Pharmaceuticals Holding Corp. (TNXP)Financial Contrast: Echo Therapeutics (ECTE) vs. Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - November 19 at 7:12 AM
Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV) Head to Head ContrastEcho Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV) Head to Head Contrast
www.americanbankingnews.com - November 18 at 5:20 PM
Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE)Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 16 at 3:36 PM
Echo Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head ReviewEcho Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head Review
www.americanbankingnews.com - November 16 at 5:20 AM
Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE) Head-To-Head ComparisonTonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE) Head-To-Head Comparison
www.americanbankingnews.com - November 15 at 10:10 AM

SEC Filings

Echo Therapeutics (OTCMKTS:ECTE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Echo Therapeutics (OTCMKTS:ECTE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Echo Therapeutics (OTCMKTS ECTE) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.